The activist shareholder has spent more than $1 billion investing in the company, according to the person, who asked not to be identified discussing confidential information.
A representative for Elliott declined to comment, while a spokesperson for BioMarin didn’t immediately respond to a request for comment. Elliott’s investment in BioMarin was reported earlier on Tuesday by Reuters.
Shares of BioMarin rose as much as 13% on Tuesday, the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.